Search research articles
Contact Us
Filters
Showing results (101-110 of 127) with videos related to
Page
of 13
Sort By:
Breast Cancer Research and Treatment
|
May 29, 2025
Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes
Arielle J Medford, Marko Velimirovic, Yifat Gefen, et al.
Critical Reviews in Oncology/Hematology
|
May 8, 2024
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways
Brenno Pastò, Giulia Buzzatti, Clorinda Schettino, et al.
Eclinicalmedicine
|
October 13, 2025
Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: a systematic review and network meta-analysis
Roberto Buonaiuto, Mario Fordellone, Aldo Caltavituro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2023
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
Whitney L Hensing, Lorenzo Gerratana, Katherine Clifton, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 6, 2019
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
Debora Basile, Annamaria Parnofiello, Maria Grazia Vitale, et al.
Cancer
|
May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025
Eleonora Nicolò, François Bertucci, Hamouda Boussen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumors
Eleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 11, 2025
Corrigendum to "International expert consensus on the clinical integration of circulating tumor cells in solid tumors" [Eur. J. Cancer 231 (2025) 116050]
Eleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
Scientific Reports
|
April 26, 2020
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis
Lorenzo Gerratana, Debora Basile, Barbara Toffoletto, et al.
Cancers
|
April 23, 2022
Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review
Mattia Garutti, Gaia Griguolo, Andrea Botticelli, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 127) with videos related to
Sort By:
Page
of 13
Breast Cancer Research and Treatment
|
May 29, 2025
Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes
Arielle J Medford, Marko Velimirovic, Yifat Gefen, et al.
Critical Reviews in Oncology/Hematology
|
May 8, 2024
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways
Brenno Pastò, Giulia Buzzatti, Clorinda Schettino, et al.
Eclinicalmedicine
|
October 13, 2025
Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: a systematic review and network meta-analysis
Roberto Buonaiuto, Mario Fordellone, Aldo Caltavituro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2023
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
Whitney L Hensing, Lorenzo Gerratana, Katherine Clifton, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 6, 2019
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
Debora Basile, Annamaria Parnofiello, Maria Grazia Vitale, et al.
Cancer
|
May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025
Eleonora Nicolò, François Bertucci, Hamouda Boussen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumors
Eleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 11, 2025
Corrigendum to "International expert consensus on the clinical integration of circulating tumor cells in solid tumors" [Eur. J. Cancer 231 (2025) 116050]
Eleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
Scientific Reports
|
April 26, 2020
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis
Lorenzo Gerratana, Debora Basile, Barbara Toffoletto, et al.
Cancers
|
April 23, 2022
Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review
Mattia Garutti, Gaia Griguolo, Andrea Botticelli, et al.
Page
of 13